These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3987044)

  • 1. Urinary glycosaminoglycans in aspartylglycosaminuria: evidence for disturbed proteoglycan metabolism.
    Näntö-Salonen K; Larjava H; Aalto M; Kivimäki T
    Clin Chim Acta; 1985 Mar; 146(2-3):111-8. PubMed ID: 3987044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of collagen in aspartylglycosaminuria: urinary excretion of hydroxyproline.
    Näntö-Salonen K; Autio S; Härö E; Kivimäki T; Koskela SL; Näntö V; Penttinen R
    J Inherit Metab Dis; 1984; 7(3):117-21. PubMed ID: 6438393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartylglycosaminuria: an inborn error of glycoprotein catabolism.
    Maury CP
    J Inherit Metab Dis; 1982; 5(4):192-6. PubMed ID: 6820440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbed metabolism of copper and zinc in aspartylglycosaminuria: possible involvement with connective tissue changes.
    Näntö-Salonen K; Halme T; Penttinen R; Langevelde FV; Vis RD; Alfthan G
    J Inherit Metab Dis; 1985; 8(4):212-8. PubMed ID: 3939546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal dermal proteoglycan in aspartylglycosaminuria: a possible mechanism for ultrastructural changes of collagen fibrils in a glycoprotein storage disorder.
    Näntö-Salonen K; Larjava H; Säämanen AM; Heino J; Penttinen R; Pelliniemi LJ; Tammi M
    Connect Tissue Res; 1987; 16(4):367-76. PubMed ID: 3132350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of collagen in aspartylglycosaminuria: decreased synthesis by cultured fibroblasts.
    Näntö-Salonen K; Penttinen R
    J Inherit Metab Dis; 1982; 5(4):197-203. PubMed ID: 6820441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Acetylglucosamine-asparagine levels in tissues of patients with aspartylglycosaminuria.
    Maury CP; Palo J
    Clin Chim Acta; 1980 Dec; 108(2):293-9. PubMed ID: 7449147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory detection of aspartylglycosaminuria.
    Mononen I; Kaartinen V; Mononen T
    Scand J Clin Lab Invest Suppl; 1988; 191():7-11. PubMed ID: 3247584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of aspartylglycosaminuria by gas--liquid chromatography.
    Maury CP
    Clin Chem; 1981 Dec; 27(12):2058-60. PubMed ID: 7307258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylglucosamine 6-sulphatase deficiency in a Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID).
    Thompson JN; Jones MZ; Dawson G; Huffman PS
    J Inherit Metab Dis; 1992; 15(5):760-8. PubMed ID: 1434515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal collagen fibrils in aspartylglycosaminuria. Altered dermal ultrastructure in a glycoprotein storage disorder.
    Näntö-Salonen K; Pelliniemi LJ; Autio S; Kivimäki T; Rapola J; Penttinen R
    Lab Invest; 1984 Oct; 51(4):464-8. PubMed ID: 6592395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid-chromatographic detection of aspartylglycosaminuria.
    Mononen T; Parviainen M; Penttilä I; Mononen I
    Clin Chem; 1986 Mar; 32(3):501-2. PubMed ID: 3948393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low urinary excretion of heparan sulfate in three patients with Lowe's syndrome.
    Yokoi T; Uozaki T; Kasei M; Sato T; Taniguchi N
    Clin Chim Acta; 1981 Oct; 116(2):153-60. PubMed ID: 6457705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of acid glycosaminoglycans and hydroxyproline in a patient with oculo-cerebro-renal syndrome.
    Hayashi S; Nagata T; Kimura A; Tsurumi K
    Tohoku J Exp Med; 1978 Nov; 126(3):215-23. PubMed ID: 734646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of 4-N-2-acetamido-2-deoxy-beta-D-glucopyranosyl-L-asparagine in the urine of patients with aspartylglycosaminuria by gas-liquid chromatography.
    Maury P
    J Lab Clin Med; 1979 May; 93(5):718-23. PubMed ID: 429870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compositional changes of urinary acidic glycosaminoglycans in progressive systemic sclerosis.
    Murata K; Takeda M
    Clin Chim Acta; 1980 Nov; 108(1):49-59. PubMed ID: 6778637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
    De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
    J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
    De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
    J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartylglycosaminuria diagnosed by routine urine amino acid assay.
    Rudy JL
    Clin Chem; 1988 Oct; 34(10):2164. PubMed ID: 3168251
    [No Abstract]   [Full Text] [Related]  

  • 20. Undersulfated urinary glycosaminoglycans in preterm newborns.
    Coppa GV; Gabrielli O; Maiorana A; Sani S; Benincasa A; Belsito M; Montali U
    Biol Neonate; 1978; 33(1-2):18-24. PubMed ID: 656519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.